Skip to content

Stoke Therapeutics

US · STOK #2942 by market cap Listed 2019
26.81 -0.12 -0.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 6 analysts

Buy
Avg price target 48.33 +80.3%
Price target rangecurrent 26.81
Low39.00
Avg48.33
High60.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-02 CCORF -- Buy 58.00
2026-11-02 H.C. Wainwright -- Buy 50.00
2026-11-01 BTIG -- Buy 39.00
2026-10-30 Goldman Sachs -- Buy 43.00
2026-10-13 TD Cowen -- Buy 60.00
2026-10-12 BTIG -- Buy 39.00
2026-10-05 Goldman Sachs -- Buy 44.00
2026-08-21 J.P. Morgan -- Buy 40.00
2026-08-12 CCORF -- Buy 58.00
2026-08-04 TD Cowen -- Buy 60.00
2026-08-04 CCORF -- Buy 58.00
2026-08-04 Needham -- Buy 40.00
2026-08-04 H.C. Wainwright -- Buy 50.00
2026-08-03 Chardan Capital -- Buy 35.00
2026-08-03 Wolfe Research -- Buy 40.00
2026-08-03 BTIG -- Buy 39.00
2026-08-03 Goldman Sachs -- Buy 44.00
2026-07-13 Goldman Sachs -- Buy 44.00
2026-07-09 Needham -- Buy 40.00
2026-06-02 Leerink Partners -- Buy --
2026-05-11 BTIG -- Buy 39.00
2026-05-08 CCORF -- Buy 60.00
2026-05-08 Wedbush -- Buy 38.00
2026-05-08 Needham -- Buy 40.00
2026-05-08 H.C. Wainwright -- Buy 50.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 After close ±16.84% -0.23% (in line)
2026/Q2 2026-08-03 After close ±10.11% +7.14% (in line)
2026/Q1 2026-05-07 After close ±17.54% +0.31% (in line)
2025/Q3 2025-11-04 After close ±20.89% -9.94% (in line)
2025/Q2 2025-08-12 After close ±20.92% +24.98% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Stoke Therapeutics discussion 0 comments

Add a comment